Kevin J Harrington (Kevin Harrington)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 55

Top Venues

Journal for immunotherapy of cancer

Cell death & disease

Nature communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Institute of Cancer Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Cancer Research Jun 19 2001

United Kingdom

Head of Division of Radiotherapy and Imaging :: Radiotherapy and Imaging

Publications

Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Emmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak, Magnus T Dillon, Anton Patrikeev, Martin McLaughlin, Lorna Grove, Shane Foo, Heba Soliman, Joao P Barata, Joanna Marsden, Holly Baldock, Jim Gkantalis, Victoria Roulstone, Joan Kyula, Amy Burley, Lisa Hubbard, Malin Pedersen, Simon A Smith, Eleanor Clancy-Thompson, Alan A Melcher, Masahiro Ono, Antonio José Rullán, Kevin J Harrington
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy. Nature communications 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Pablo Jimenez-Labaig, Claudia Aymerich, Irene Brana, Antonio José Rullán, Jon Cacicedo, Miguel Ángel González-Torres, Kevin J Harrington, Ana Catalan
A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis. JNCI cancer spectrum 8 (3) (2024)
Ann-Marie C Baker, Gayathri Nageswaran, Pablo Nenclares, Tahel Ronel, Kane Smith, Christopher Kimberley, Miangela M Laclé, Shreerang A Bhide, Kevin J Harrington, Alan A Melcher, Manuel Rodriguez, Benjamin M Chain, Trevor A Graham
FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA. Cancer research 84 (10) (2024)
Emmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak, Magnus T Dillon, Anton Patrikeev, Martin McLaughlin, Lorna Grove, Shane Foo, Heba Soliman, Joao P Barata, Joanna Marsden, Holly Baldock, Jim Gkantalis, Victoria Roulstone, Joan Kyula, Amy Burley, Lisa Hubbard, Malin Pedersen, Simon A Smith, Eleanor Clancy-Thompson, Alan A Melcher, Masahiro Ono, Antonio José Rullán, Kevin J Harrington
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy. Nature communications 15 (1) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Pablo Jimenez-Labaig, Claudia Aymerich, Irene Brana, Antonio José Rullán, Jon Cacicedo, Miguel Ángel González-Torres, Kevin J Harrington, Ana Catalan
A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis. JNCI cancer spectrum 8 (3) (2024)
Pablo Jimenez-Labaig, Claudia Aymerich, Irene Brana, Antonio José Rullán, Jon Cacicedo, Miguel Ángel González-Torres, Kevin J Harrington, Ana Catalan
A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis. JNCI cancer spectrum 8 (3) (2024)
Pablo Jimenez-Labaig, Claudia Aymerich, Irene Brana, Antonio José Rullán, Jon Cacicedo, Miguel Ángel González-Torres, Kevin J Harrington, Ana Catalan
A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis. JNCI cancer spectrum 8 (3) (2024)
Michael J Dubec, James M Price, Michael Berks, John Gaffney, Ross A Little, Nuria Porta, Nivetha Sridharan, Anubhav Datta, Damien J McHugh, Christina J Hague, Susan Cheung, Prakash Manoharan, Marcel B van Herk, Ananya Choudhury, Julian C Matthews, Geoffrey J M Parker, David L Buckley, Kevin J Harrington, Andrew J McPartlin, James P B O'Connor
Oxygen-enhanced MRI detects incidence, onset and heterogeneity of radiation-induced hypoxia modification in HPV-associated oropharyngeal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Emmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak, Magnus T Dillon, Anton Patrikeev, Martin McLaughlin, Lorna Grove, Shane Foo, Heba Soliman, Joao P Barata, Joanna Marsden, Holly Baldock, Jim Gkantalis, Victoria Roulstone, Joan Kyula, Amy Burley, Lisa Hubbard, Malin Pedersen, Simon A Smith, Eleanor Clancy-Thompson, Alan A Melcher, Masahiro Ono, Antonio José Rullán, Kevin J Harrington
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy. Nature communications 15 (1) (2024)
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Emmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak, Magnus T Dillon, Anton Patrikeev, Martin McLaughlin, Lorna Grove, Shane Foo, Heba Soliman, Joao P Barata, Joanna Marsden, Holly Baldock, Jim Gkantalis, Victoria Roulstone, Joan Kyula, Amy Burley, Lisa Hubbard, Malin Pedersen, Simon A Smith, Eleanor Clancy-Thompson, Alan A Melcher, Masahiro Ono, Antonio José Rullán, Kevin J Harrington
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy. Nature communications 15 (1) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Emmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak, Magnus T Dillon, Anton Patrikeev, Martin McLaughlin, Lorna Grove, Shane Foo, Heba Soliman, Joao P Barata, Joanna Marsden, Holly Baldock, Jim Gkantalis, Victoria Roulstone, Joan Kyula, Amy Burley, Lisa Hubbard, Malin Pedersen, Simon A Smith, Eleanor Clancy-Thompson, Alan A Melcher, Masahiro Ono, Antonio José Rullán, Kevin J Harrington
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy. Nature communications 15 (1) (2024)
Ann-Marie C Baker, Gayathri Nageswaran, Pablo Nenclares, Tahel Ronel, Kane Smith, Christopher Kimberley, Miangela M Laclé, Shreerang A Bhide, Kevin J Harrington, Alan A Melcher, Manuel Rodriguez, Benjamin M Chain, Trevor A Graham
FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA. Cancer research 84 (10) (2024)
Ann-Marie C Baker, Gayathri Nageswaran, Pablo Nenclares, Tahel Ronel, Kane Smith, Christopher Kimberley, Miangela M Laclé, Shreerang A Bhide, Kevin J Harrington, Alan A Melcher, Manuel Rodriguez, Benjamin M Chain, Trevor A Graham
FUME-TCRseq enables sensitive and accurate sequencing of the T-cell receptor from limited input of degraded RNA. Cancer research (2024)
Ann-Marie C Baker, Gayathri Nageswaran, Pablo Nenclares, Tahel Ronel, Kane Smith, Christopher Kimberley, Miangela M Laclé, Shreerang A Bhide, Kevin J Harrington, Alan A Melcher, Manuel Rodriguez, Benjamin M Chain, Trevor A Graham
FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA. Cancer research 84 (10) (2024)
Charles M Rudin, Hardev S Pandha, Matthew Zibelman, Wallace L Akerley, Kevin J Harrington, Daphne Day, Andrew G Hill, Steven J O'Day, Timothy D Clay, Gavin M Wright, Ross R Jennens, David E Gerber, Jonathan E Rosenberg, Christy Ralph, David C Campbell, Brendan D Curti, Jaime R Merchan, Yixin Ren, Emmett V Schmidt, Lisa Guttman, Sumati V Gupta
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors. Journal for immunotherapy of cancer 11 (1) (2023)
Hisham Mehanna, Davy Rapozo, Sandra Lucia Ventorin Von Zeidler, Kevin J Harrington, Stuart C Winter, Andrew Hartley, Paul Nankivell, Andrew Graeme Schache, Philip Sloan, Edward William Odell, Selvam Thavaraj, Keith David Hunter, Ketan A Shah, Gareth J Thomas, Anna Long, Rasoul Amel-Kashipaz, Rachel M Brown, Brendan Conn, Gillian L Hall, Paul Matthews, Justin Weir, Yen Yeo, Miranda Pring, Catharine M L West, James McCaul, Paweł Golusinski, Alice J Sitch, Rachel Spruce, Nikolaos Batis, Jennifer L Bryant, Jill M Brooks, Terence M Jones, Francesca M Buffa, Syed Haider, Max Robinson
Developing and validating a multivariable prognostic-predictive classifier for treatment escalation of oropharyngeal squamous cell carcinoma: the PREDICTR-OPC study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, Nina Bhardwaj, Charleen Chan Wah Hak, Alba Fiorentino, Chandan Guha, Monica L Guzman, Kevin J Harrington, Fernanda G Herrera, Jamie Honeychurch, Theodore S Hong, Lorea Iturri, Elisabeth Jaffee, Sana D Karam, Simon R V Knott, Constantinos Koumenis, David C Lyden, Ariel E Marciscano, Alan A Melcher, Michele Mondini, Anna Mondino, Zachary S Morris, Sean P Pitroda, Sergio A Quezada, Laura Santambrogio, Stephen L Shiao, John Stagg, Irma Telarovic, Robert Timmerman, Marie-Catherine Vozenin, Ralph R Weichselbaum, James Welsh, Anna C Wilkins, Chris Xu, Roberta Zappasodi, Weiping Zou, Alexandre Bobard, Sandra Demaria, Lorenzo Galluzzi, Eric Deutsch, Sylvia C Formenti
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference. Oncoimmunology 12 (1) (2023)
Charles M Rudin, Hardev S Pandha, Matthew Zibelman, Wallace L Akerley, Kevin J Harrington, Daphne Day, Andrew G Hill, Steven J O'Day, Timothy D Clay, Gavin M Wright, Ross R Jennens, David E Gerber, Jonathan E Rosenberg, Christy Ralph, David C Campbell, Brendan D Curti, Jaime R Merchan, Yixin Ren, Emmett V Schmidt, Lisa Guttman, Sumati V Gupta
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors. Journal for immunotherapy of cancer 11 (1) (2023)
Charles M Rudin, Hardev S Pandha, Matthew Zibelman, Wallace L Akerley, Kevin J Harrington, Daphne Day, Andrew G Hill, Steven J O'Day, Timothy D Clay, Gavin M Wright, Ross R Jennens, David E Gerber, Jonathan E Rosenberg, Christy Ralph, David C Campbell, Brendan D Curti, Jaime R Merchan, Yixin Ren, Emmett V Schmidt, Lisa Guttman, Sumati V Gupta
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors. Journal for immunotherapy of cancer 11 (1) (2023)
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, Nina Bhardwaj, Charleen Chan Wah Hak, Alba Fiorentino, Chandan Guha, Monica L Guzman, Kevin J Harrington, Fernanda G Herrera, Jamie Honeychurch, Theodore S Hong, Lorea Iturri, Elisabeth Jaffee, Sana D Karam, Simon R V Knott, Constantinos Koumenis, David C Lyden, Ariel E Marciscano, Alan A Melcher, Michele Mondini, Anna Mondino, Zachary S Morris, Sean P Pitroda, Sergio A Quezada, Laura Santambrogio, Stephen L Shiao, John Stagg, Irma Telarovic, Robert Timmerman, Marie-Catherine Vozenin, Ralph R Weichselbaum, James Welsh, Anna C Wilkins, Chris Xu, Roberta Zappasodi, Weiping Zou, Alexandre Bobard, Sandra Demaria, Lorenzo Galluzzi, Eric Deutsch, Sylvia C Formenti
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference. Oncoimmunology 12 (1) (2023)
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, Nina Bhardwaj, Charleen Chan Wah Hak, Alba Fiorentino, Chandan Guha, Monica L Guzman, Kevin J Harrington, Fernanda G Herrera, Jamie Honeychurch, Theodore S Hong, Lorea Iturri, Elisabeth Jaffee, Sana D Karam, Simon R V Knott, Constantinos Koumenis, David C Lyden, Ariel E Marciscano, Alan A Melcher, Michele Mondini, Anna Mondino, Zachary S Morris, Sean P Pitroda, Sergio A Quezada, Laura Santambrogio, Stephen L Shiao, John Stagg, Irma Telarovic, Robert Timmerman, Marie-Catherine Vozenin, Ralph R Weichselbaum, James Welsh, Anna C Wilkins, Chris Xu, Roberta Zappasodi, Weiping Zou, Alexandre Bobard, Sandra Demaria, Lorenzo Galluzzi, Eric Deutsch, Sylvia C Formenti
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference. Oncoimmunology 12 (1) (2023)
Kevin J Harrington, Barbara A Burtness, Richard Greil, Denis Soulieres, Makato Tahara, Gilberto de Castro Junior, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G M Hughes, Ricard Mesía, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Jianxin Lin, Burak Gumuscu, Ramona F Swaby, Danny Rischin
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Pablo Nenclares, Lucinda Gunn, Heba Soliman, Mateo Bover, Amy Trinh, Isla Leslie, Kee Howe Wong, Alan Melcher, Kate Newbold, Chris M Nutting, Derfel Ap Dafydd, Shreerang A Bhide, Kevin J Harrington
On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy. Journal for immunotherapy of cancer 9 (6) (2022)
Robert I Haddad, Kevin J Harrington, Makato Tahara, Matthew J Ferris, Maura Gillison, Jerome Fayette, Amaury Daste, Piotr Koralewski, Bogdan Zurawski, Miren Taberna, Nabil F Saba, Milena Perez Mak, Andrzej Kawecki, Gustavo C Girotto, Miguel Angel Alvarez Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander D Guminski, Urs D A Müller-Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Li Wei, Athanassios Argiris
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Barbara A Burtness, Danny Rischin, Richard Greil, Denis Soulieres, Makato Tahara, Gilberto de Castro Junior, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G M Hughes, Ricard Mesía, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Joy Ge, Ramona F Swaby, Burak Gumuscu, Kevin J Harrington
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Alessio Cortellini, Gino M Dettorre, Urania Dafni, Juan Aguilar-Company, Luis Castelo-Branco, Matteo Lambertini, Spyridon Gennatas, Vasileios Angelis, Ailsa Sita-Lumsden, Jacobo Rogado, Paolo Pedrazzoli, David Viñal, Aleix Prat, Maura Rossi, Rossana Berardi, Teresa Alonso-Gordoa, Salvatore Grisanti, Georgia Dimopoulou, Paola Queirolo, Sylvain Pradervand, Alexia Bertuzzi, Mark Bower, Dirk Arnold, Ramón Salazar, Marco Tucci, Kevin J Harrington, Francesca Mazzoni, Uma Mukherjee, Zoi Tsourti, Olivier Michielin, Fanny Pommeret, Joan Brunet, Bruno Vincenzi, Giuseppe Tonini, Andrea Patriarca, Federica Biello, Marco Krengli, Josep Tabernero, George Pentheroudakis, Alessandra Gennari, Solange Peters, Emanuela Romano, David James Pinato
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries. Journal for immunotherapy of cancer 10 (11) (2022)
Rebecca Jane Lee, Oskar Wysocki, Cong Zhou, Rohan Shotton, Ann Tivey, Louise Lever, Joshua Woodcock, Laurence Albiges, Angelos Angelakas, Dirk Arnold, Theingi Aung, Kathryn Banfill, Mark A Baxter, Fabrice Barlesi, Arnauld Bayle, Benjamin Besse, Talvinder Bhogal, Hayley Boyce, Fiona Britton, Antonio Calles, Luis Castelo-Branco, Ellen Copson, Adina Emilia Croitoru, Sourbha S Dani, Elena Dickens, Leonie Eastlake, Paul Fitzpatrick, Stephanie Foulon, Henrik Frederiksen, Hannah Frost, Sarju Ganatra, Spyridon Gennatas, Andreas Glenthoej, Fabio Gomes, Donna M Graham, Christina Hague, Kevin J Harrington, Michelle Harrison, Laura Horsley, Richard Hoskins, Prerana Huddar, Zoe Hudson, Lasse Hjort Kyneb Jakobsen, Nalinie Joharatnam-Hogan, Sam Khan, Umair T Khan, Khurum Khan, Christophe Massard, Alec Maynard, Hayley McKenzie, Olivier Michielin, Anne C Mosenthal, Berta Obispo-Portero, Rushin Patel, George Pentheroudakis, Solange Peters, Kimberly Rieger-Christ, Timothy Robinson, Jacobo Rogado, Emanuela Romano, Michael Rowe, Marina Sekacheva, Roseleen Sheehan, Julie Stevenson, Alexander J Stockdale, Anne Thomas, Lance C W Turtle, David Viñal, Jamie Weaver, Sophie T Williams, Caroline Wilson, Carlo Palmieri, Dónal Landers, Timothy Cooksley, null null, Caroline Dive, André Freitas, Anne C Armstrong
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital. JCO clinical cancer informatics 6 (2022)
Galabina Bozhanova, Jehanne Hassan, Lizzie Appleton, Victoria Jennings, Shane Foo, Martin McLaughlin, Charleen Ml Chan Wah Hak, Emmanuel C Patin, Eva Crespo-Rodriguez, Gabby Baker, Edward Armstrong, Matthew Chiu, Hardev Pandha, Adel Samson, Victoria Roulstone, Joan Kyula, Richard Vile, Fiona Errington-Mais, Malin Pedersen, Kevin J Harrington, Masahiro Ono, Alan A Melcher
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma. Journal for immunotherapy of cancer 10 (3) (2022)
Laura Evgin, Tim Kottke, Jason Tonne, Jill Thompson, Amanda L Huff, Jacob P van Vloten, Madelyn Moore, Josefine Michael, Christopher B Driscoll, Jose Pulido, Eric Swanson, Richard B Kennedy, Matthew Coffey, Houra Loghmani, Luis Sanchez-Perez, Gloria R Olivier, Kevin J Harrington, Hardev Pandha, Alan A Melcher, Rosa Maria Diaz, Richard G Vile
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice. Science translational medicine 14 (640) (2022)
Emmanuel C Patin, Magnus T Dillon, Pablo Nenclares, Lorna Grove, Heba Soliman, Isla Leslie, Davina Northcote, Galabina Bozhanova, Eva Crespo-Rodriguez, Holly Baldock, Harriet Whittock, Gabriella Baker, Joan Kyula, Jeane Guevara, Alan A Melcher, James Harper, Hormas Ghadially, Simon Smith, Malin Pedersen, Martin McLaughlin, Kevin J Harrington
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade. Journal for immunotherapy of cancer 10 (3) (2022)
Victoria Roulstone, David Mansfield, Robert J Harris, Katie Twigger, Christine White, Johann de Bono, James F Spicer, Sophia N Karagiannis, Richard Vile, Hardev Pandha, Alan Melcher, Kevin J Harrington
Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies. Journal for immunotherapy of cancer 9 (7) (2022)
John C Hardman, Floyd Christopher Holsinger, Gráinne C Brady, Avinash Beharry, Alec T Bonifer, Gregoire D'Andréa, Surender K Dabas, John R De Almeida, Umamaheswar Duvvuri, Peter Floros, Tamer A Ghanem, Philippe Gorphe, Neil D Gross, David Winston Hamilton, Chareeni Kurukulasuriya, Mikkel Hjordt Holm Larsen, Daniel J Lin, Jeffery Scott Magnuson, Meulemans Jeroen, Brett A Miles, Eric J Moore, Suhail Siddiqui, Scott A Roof, Niclas Rubek, Christian Simon, Anand Subash, Michael C Topf, Kathryn M Van Abel, Vander Poorten Vincent, Evan S Walgama, Emily J Robinson, Laura C Potts, Arun Balaji, Heather M Starmer, Sarah Stephen, Justin W G Roe, Kevin J Harrington, Vinidh Paleri
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study. Journal of the National Cancer Institute 114 (10) (2022)
Annika Fendler, Lewis Au, Scott T C Shepherd, Fiona Byrne, Maddalena Cerrone, Laura Amanda Boos, Karolina Rzeniewicz, William Gordon, Benjamin Shum, Camille L Gerard, Barry Ward, Wenyi Xie, Andreas M Schmitt, Nalinie Joharatnam-Hogan, Georgina H Cornish, Martin A Pule, Leila Mekkaoui, Kevin W Ng, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, Sarah Sarker, Karla Lingard, Mary Mangwende, Lucy Holt, Hamid Ahmod, Richard Stone, Camila Araujo De Carvalho Gomes, Helen R Flynn, Ana Agua-Doce, Philip Hobson, Simon Caidan, Michael Howell, Mary Y Wu, Robert Goldstone, Margaret Crawford, Laura Cubitt, Harshil Patel, Mike Gavrielides, Emma Nye, Ambrosius P Snijders, James I MacRae, Jérôme Nicod, Firza Gronthoud, Robyn L Shea, Christina Messiou, David Cunningham, Ian Chau, Naureen Starling, Nicholas Turner, Liam Welsh, Nicholas van As, Robin L Jones, Joanne Droney, Susana Banerjee, Kate C Tatham, Shaman Jhanji, Mary O'Brien, Olivia Curtis, Kevin J Harrington, Shreerang Bhide, Jessica Bazin, Anna Robinson, Clemency Stephenson, Tim Slattery, Yasir Khan, Zayd Tippu, Isla Leslie, Spyridon Gennatas, Alicia Okines, Alison Reid, Kate Young, Andrew J S Furness, Lisa M Pickering, Sonia Gandhi, Steven J Gamblin, Charles Swanton, null null, Emma Nicholson, Sacheen Kumar, Nadia Yousaf, Katalin Andrea Wilkinson, Anthony Swerdlow, Ruth Harvey, George Kassiotis, James Larkin, Robert J Wilkinson, Samra Turajlic, null null
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study. Nature cancer 2 (12) (2021)
Lisa Haas, Anais Elewaut, Camille L Gerard, Christian Umkehrer, Lukas Leiendecker, Malin Pedersen, Izabela Krecioch, David Hoffmann, Maria Novatchkova, Mario Kuttke, Tobias Neumann, Ines Pires da Silva, Harriet Witthock, Michel A Cuendet, Sebastian Carotta, Kevin J Harrington, Johannes Zuber, Richard A Scolyer, Georgina V Long, James S Wilmott, Olivier Michielin, Sakari Vanharanta, Thomas Wiesner, Anna C Obenauf
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma. Nature cancer 2 (7) (2021)
Alan L Ho, Irene Brana, Robert I Haddad, Jessica Bauman, Keith C Bible, Sjoukje Oosting, Deborah J Wong, Myung-Ju Ahn, Valentina Boni, Caroline Even, Jerome Fayette, Maria José Flor, Kevin J Harrington, Sung-Bae Kim, Lisa F Licitra, Ioanna Nixon, Nabil F Saba, Stephan Hackenberg, Pol Specenier, Francis Worden, Binaifer Balsara, Mollie Leoni, Bridget Martell, Catherine Scholz, Antonio Gualberto
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (17) (2021)
Timothy Kottke, Jason Tonne, Laura Evgin, Christopher B Driscoll, Jacob P van Vloten, Victoria A Jennings, Amanda L Huff, Brady Zell, Jill M Thompson, Phonphimon Wongthida, Jose Pulido, Matthew R Schuelke, Adel Samson, Peter Selby, Elizabeth J Ilett, Mark McNiven, Lewis Rowland Roberts, Mitesh J Borad, Hardev Pandha, Kevin J Harrington, Alan Melcher, Richard G Vile
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nature communications 12 (1) (2021)
Justyna Mączyńska, Chiara Da Pieve, Thomas A Burley, Florian Raes, Anant Shah, Jolanta Saczko, Kevin J Harrington, Gabriela Kramer-Marek
Immunomodulatory activity of IR700-labelled affibody targeting HER2. Cell death & disease 11 (10) (2020)
Kenneth Emancipator, Lingkang Huang, Deepti Aurora-Garg, Tricia Bal, Ezra E W Cohen, Kevin J Harrington, Denis Soulières, Christophe Le Tourneau, Lisa Licitra, Barbara Burtness, Ramona Swaby
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (3) (2020)

Kevin J Harrington.css-eqlu8i{font-size:small;padding-left:4px;} (Kevin Harrington)

Publication Activity (10 Years)

Top Topics

Top Venues

Kevin J Harrington (Kevin Harrington)